logo
Book a meeting
OncoSenX

Onco Sen X

Biotechnology, 800 5th Ave, Seattle, Washington, 98104, United States, 1-10 Employees

oncosenx.com

  • facebook
  • LinkedIn

phone no Phone Number: 20********

Who is ONCOSENX

OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticl...

Read More

lock icon Get Full Access
map
  • 800 5th Ave, Seattle, Washington, 98104, United States Headquarters: 800 5th Ave, Seattle, Washington, 98104, United States
  • 2017 Date Founded: 2017
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ONCOSENX

OncoSenX Org Chart and Mapping

Employees
Stephen Hilbert

Stephen Hilbert

Chief Business Officer

See Full Org Chart arrow
email-formate-icon
View Email Formats for OncoSenX
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding OncoSenX

Answer: OncoSenX's headquarters are located at 800 5th Ave, Seattle, Washington, 98104, United States

Answer: OncoSenX's phone number is 20********

Answer: OncoSenX's official website is https://oncosenx.com

Answer: OncoSenX's revenue is $5 Million to $10 Million

Answer: OncoSenX's SIC: 2834

Answer: OncoSenX's NAICS: 325412

Answer: OncoSenX has 1-10 employees

Answer: OncoSenX is in Biotechnology

Answer: OncoSenX contact info: Phone number: 20******** Website: https://oncosenx.com

Answer: OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA. The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access